Ozempic (injectable, weekly, 0.25mg, 0.5mg, 1.0mg, 2.0mg) and Rybelsus (oral, daily, 7mg, 14mg) are FDA-approved for type 2 diabetes, while Wegovy (injectable, weekly, 0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg) is approved for obesity
Switching from Ozempic to Zepbound In some circumstances, it might be preferable to transition from Ozempic to Zepbound, particularly for those patients, who have been taking Ozempic for off-label to lose weight and it is not very effective
If your employer does not currently cover these medications, advocating for their inclusion could benefit you and coworkers facing similar challenges
If you experience any serious side effects, such as severe abdominal pain, persistent vomiting, or signs of an allergic reaction (rash, itching, swelling, difficulty breathing), seek medical attention immediately